Biochemistry, Genetics and Molecular Biology
down Regulation
94%
Carcinogenesis
82%
Signal Transduction
81%
Quantitative Reverse Transcription Polymerase Chain Reaction
78%
Overall Survival
76%
Recurrence Free Survival
68%
Disease Free Survival
65%
Progression Free Survival
64%
Gene Signature
62%
MiR-132
62%
Epidermal Growth Factor Receptor
62%
P53
62%
Cancer Cell
44%
Protein-Protein Interaction
41%
Multivariate Analysis
39%
Fibroblast
35%
Cell Proliferation
32%
Solution and Solubility
31%
Integrin
31%
Biogenesis
31%
Event Free Survival
31%
Protein Expression
31%
Tumor Volume
31%
E2F1
31%
Tissue Microarray
31%
Antisense RNA
31%
Matrix Metalloproteinase
31%
Vascular Endothelial Growth Factor
31%
Astrocyte
31%
Natural Language Processing
31%
Gene Expression Profiling
31%
Anticancer
31%
Galectin-3
31%
Hemocyte
31%
Vimentin
31%
Observational Study
31%
Smad1 Protein
31%
Bone Morphogenetic Protein
31%
DNA Damage Response
31%
Medline
25%
Web of Science
25%
Cancer Specific Survival
22%
Mesenchymal-Epithelial Transition
19%
Reverse Transcription
15%
Gene Therapy
15%
Gene Expression
15%
Vasoactive Intestinal Peptide
14%
Neurotrophin
13%
Adherens Junction
13%
Hub Genes
13%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
93%
Liver Cell Carcinoma
88%
Non Small Cell Lung Cancer
62%
Protein P53
62%
Carcinogenesis
55%
Biological Marker
44%
Epidermal Growth Factor Receptor
35%
microRNA 132
31%
Galectin 3
31%
Metastatic Breast Cancer
31%
Solid Malignant Neoplasm
31%
Observational Study
31%
Drug Carrier
31%
Combination Therapy
31%
Complementary RNA
31%
Vimentin
31%
microRNA 34a
31%
Nasopharynx Carcinoma
31%
Biocompatibility
31%
Digestive System Cancer
31%
Liver Carcinogenesis
31%
Drug Delivery System
31%
Disease Free Survival
31%
Integrin
31%
Recurrence Free Survival
31%
Drug Development
31%
Systemic Administration
31%
Smad1 Protein
31%
Bone Morphogenetic Protein
31%
Overall Survival
30%
Event Free Survival
20%
Progression Free Survival
20%
Lymph Node Metastasis
19%
Formaldehyde
18%
Squamous Cell Carcinoma
15%
Anticarcinogen
15%
Immunotherapy
15%
Distant Metastasis
15%
Vasoactive Intestinal Polypeptide
14%
Tumor Growth
12%
Colorectal Carcinoma
10%
Primary Tumor
10%
Stomach Carcinoma
10%
Gallbladder Carcinoma
10%
Gastrointestinal Carcinoma
10%
Disease Specific Survival
10%
Pancreas Adenocarcinoma
10%
Esophageal Squamous Cell Carcinoma
10%
Clinical Trial
10%
Medicine and Dentistry
Hepatocellular Carcinoma
94%
Malignant Neoplasm
89%
Metastatic Carcinoma
42%
Cancer Cell
37%
Meta-Analysis
36%
Tumor Microenvironment
33%
Integrin
31%
Protein P53
31%
Tissue Microarray
31%
Epidermal Growth Factor Receptor
31%
microRNA 132
31%
Nasopharynx Carcinoma
31%
Cancer Therapy
31%
Gene Expression Profiling
31%
Galectin 3
31%
Ganglioglioma
31%
Therapeutic Agent
31%
Vasculotropin
31%
Metastatic Breast Cancer
31%
Drug Delivery System
31%
Cell Component
31%
Stromal Cell
31%
Carcinogenesis
26%
Cell Communication
23%
Signal Transduction
22%
Anticarcinogen
20%
Diagnosis
20%
Formaldehyde
18%
The Cancer Genome Atlas
18%
Mesenchymal-Epithelial Transition
15%
Gene Therapy
15%
Lymph Node Metastasis
15%
Biopsy Sample
15%
Immunohistochemistry
15%
Carcinoma
15%
Language Processing
15%
Neoplasm
15%
Protein-Protein Interaction
12%
Overall Survival
12%
Doxorubicin
10%
Cancer Immunotherapy
10%
Paclitaxel
10%
Immunotherapy
10%
Rigor
10%
Natural Childbirth
10%
Breast Cancer
10%
Side Effect
10%
Reproducibility
10%
Natural Product
10%
Extracellular Matrix
10%
